Portal for life science/healthcare startups
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setting up in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device, IVD >
      • IVD, LDT, RUO
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • Classification of Medical Devices
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • Comparison of Medical Device Definitions: Japan, US, & EU
      • Companion Diagnostics and Gene Panel Testing
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
      • References on Reimbursement (Cost Calculation) for Regenerative Medical Products
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
      • Overseas Expansion of Non-Medical Device Products as Medical Devices: Learning from the Case of PARO
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
      • Matching of Patents Held by Startups and Individuals
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Networking, Partnering
      • Introducing Seeds to Pharmaceutical Companies
      • Incentives (Returns) to Licensor Universities
    • References in English
  • コンテンツ一覧
    • 起業、法人設立・運営 >
      • 事業計画の策定
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 実証実験支援プログラム一覧
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • PMDA RS相談活用のススメ
      • 薬事スタッフ・コンサル選定ガイド
      • 都道府県薬務課一覧
      • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
    • 医薬品、再生医療等製品 >
      • 医薬品の該当性確認方法
      • 医薬品一般的名称設定のガイドライン
      • 医薬品、医療機器等の開発に当たって、参照したい資料
      • 先進医療制度
      • 一般用医薬品(OTC)
      • コンパニオン診断薬と遺伝子パネル検査
      • 再生医療等製品の保険償還(原価計算)に関する参考情報
    • 医療機器、体外診断用医薬品 >
      • 体外診、ラボ開発検査、研究用試薬
      • 医療機器該当性確認ガイド
      • 医療機器と非医療機器の機能が複合した製品は?
      • 医療機器の一般的名称と確認方法
      • 医療機器のクラス分類
      • 医療機器・体外診の保険収載概要
      • 医療機器・体外診の保険収載実務
      • SaMDの保険収載
      • 医療機器・体外診の保険収載ガイド
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
      • 医療機器とするか、非医療機器とするか
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • アカデミア研究者がPIとして応募可能なグラントリスト
      • 海外在住の日本人研究者が日本の助成金を獲得する方法
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
      • スタートアップや個人が保有する特許のマッチング
      • ライセンスを受けた大学へのインセンティブ(還元)について
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時に留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
      • ネットワーキング、パートナリング
    • 海外展開 >
      • 米国展開(主に医療機器)に、読むと役立つ情報リスト
      • 米国FDAにおける、医療機器該当性の確認ステップ
      • 米国における、医療機器の申請データ・試験計画の相談方法((Pre-Submission/Q-Submission
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
      • 非医療機器製品の海外での医療機器展開
      • 欧州医療機器規則MDRに関する資料
      • 欧州MDRにおける、医療機器該当性の確認方法
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報

Therapeutic Orthoses and Assistive Devices

While both therapeutic orthoses and assistive devices serve to supplement and support bodily functions, they differ significantly in their objectives, the laws that regulate them, their methods of use, and the procedures for manufacturers to have their products covered by public systems. Furthermore, these are separate systems from the insurance reimbursement listing for medical devices under the medical service fee system, so it is necessary to consider which system to target for product commercialization from the business planning stage.


🗂️ 1. Differences in Definitions, Legal Regulations, and Target Users

Therapeutic Orthosis
  • Definition/Objective: An orthosis used temporarily during the treatment process of an illness or injury to immobilize the affected area or substitute its function. Plaster casts and corsets are typical examples.
  • Governing Law: Based on the Health Insurance Act.
  • Target Users: Individuals undergoing treatment for an illness or injury for whom a physician deems the orthosis medically necessary. In principle, individuals are no longer eligible once their symptoms have stabilized (a state where no further improvement can be expected from treatment).

Assistive Device (Hosōgu)
  • Definition/Objective: An item used for an extended period after a disability has stabilized to compensate for lost physical functions and facilitate daily and social life. This includes prosthetic arms/legs, wheelchairs, hearing aids, and walkers.
  • Governing Law: Based on the Act on Comprehensive Support for Persons with Disabilities.
  • Target Users: Individuals, such as holders of a Physical Disability Certificate, who have a permanent physical disability that impedes their daily life.


📜 2. User Procedures and Cost Burden
The procedures for users to obtain these devices and the mechanisms for cost-sharing are entirely different.
In the Case of Therapeutic Orthoses (Reimbursement Payment for Medical Expenses)
The principle is a "reimbursement payment" system, where the user temporarily pays the full amount upfront and is later reimbursed.
  • Physician's Diagnosis/Prescription: A physician determines the orthosis is necessary for treatment and creates a "Fabrication Instruction Form (Medical Opinion)".
  • Fabrication/Purchase: The user has the orthosis fabricated at a prosthetics and orthotics company and pays the full cost out-of-pocket.
  • Application for Benefits: The user applies by submitting the following documents to their health insurance provider (e.g., Japan Health Insurance Association "Kyokai Kenpo," Health Insurance Societies, or municipal National Health Insurance):
    • Application for Medical Expense Benefits
    • Physician's Medical Opinion and Certificate of Fitting
    • Receipt
  • Reimbursement: After a review, the amount minus the co-payment portion (in principle, 10-30%) is transferred to the designated bank account (meaning 70-90% is reimbursed).
  • Reference URLs:
    • Ministry of Health, Labour and Welfare: Regarding Medical Expense Benefits for Therapeutic Orthoses
    • Japan Health Insurance Association (Kyokai Kenpo): Application for Health Insurance Medical Expense Benefits (For Upfront Payments, Therapeutic Orthoses, etc.)

In the Case of Assistive Devices (Assistive Device Expense Benefit System)
Generally, a system where the user pays 10% of the cost as a co-payment (proxy receipt system) is common.
  • Consultation/Application: The user consults with and submits an application, a physician's medical opinion, and other documents to the disability welfare section of their local municipal office.
  • Evaluation: An evaluation is conducted at a Rehabilitation Center for Persons with Disabilities or a similar institution to determine if the assistive device is truly necessary.
  • Decision/Issuance of Ticket: If approved, the municipality issues an "Assistive Device Expense Benefit Decision Notice" and an "Assistive Device Expense Ticket".
  • Fabrication/Receipt: The user gives the ticket to the provider, pays, in principle, 10% of the cost, and receives the assistive device. (The remaining 90% is paid directly from the municipality to the provider.)
  • Reference URL:
    • Ministry of Health, Labour and Welfare: Overview of the Assistive Device Expense Benefit System


⚙️ 3. Manufacturer's Perspective: The Path to Product Adoption

For Ready-Made Therapeutic Orthoses: Aim for "Inclusion in the List"
In addition to custom-made items, ready-made products that meet certain requirements are also eligible for coverage. Manufacturers aim to have their products included in the list specified by the Ministry of Health, Labour and Welfare (MHLW).
  • Application: A manufacturer submits materials (survey forms and proposals) demonstrating the product's effectiveness, safety, and price validity to the Japan Orthotics & Prosthetics Association, which serves as the application window. The association organizes and reviews the content before submitting a formal proposal to the MHLW (Health Insurance Bureau, Medical Economics Division).
  • Review: Upon receiving the proposal, the MHLW requests a review by the "Working Group for Reviewing the Listing of Ready-Made Orthoses," which is composed of experts. This group assesses whether the product has functions and effects equivalent to custom-made items.
  • Listing: If approved by the working group and after final deliberation by an expert committee, the product is included in the list via a notice from the MHLW and becomes eligible for medical expense reimbursement.
  • Reference URLs:
    • [Director-General's Notice] Partial Revision of "Regarding Ready-Made Therapeutic Orthoses Eligible for Medical Expense Benefits"
    • Ministry of Health, Labour and Welfare: Regarding Medical Expense Benefits for Ready-Made Therapeutic Orthoses (Working Group Materials)

For Assistive Devices: Aim for Designation as "Finished Components"
The price of an assistive device is calculated based on standard amounts set by the government. This standard is composed of the cumulative prices of various "components," and manufacturers must have their products designated as "Finished Components" on this official price list.
  • Application Window: The National Rehabilitation Center for Persons with Disabilities serves as the application window.
  • Application: Within a specified period each year (typically July-September), manufacturers submit application forms, product samples, and clinical evaluation data.
  • Evaluation/Review: The National Rehabilitation Center for Persons with Disabilities evaluates and reviews the product's functionality, durability, and price validity.
  • Designation/Notice: Once approved, the product is designated as a "Finished Component" by a public notice from the MHLW and becomes eligible for the Assistive Device Expense Benefit System. This allows prosthetics and orthotics companies nationwide to use the component to fabricate assistive devices.
  • Reference URL:
    • National Rehabilitation Center for Persons with Disabilities: Information on the Designation of Finished Components


🔬 4. Difference from Medical Device Insurance Listing

The systems for therapeutic orthoses and assistive devices are fundamentally different from the general insurance reimbursement listing for medical devices.

Thus, while therapeutic orthoses and assistive devices are operated within the frameworks of "welfare" and "recuperation," medical devices undergo a strict approval and price determination process within the framework of "medical care," which is a major difference.


Other Reference URLs:
  • 07_Reference_Material_2.pdf
  • 04 Chi-1 Regarding Listing and Standard Price Setting for Ready-Made Therapeutic Orthoses.pdf
  • 01_Medical_Division_Chief_Notice_Therapeutic_Orthosis_Guideline_Cover.pdf
  • harness.pdf

@K.Kamitani
Picture
Picture
Home
About JPRO
Table of Contents
​
​オフィス概要
​コンテンツ一覧
Ⓒ2026 JPRO
We are the pro bono navigator for life science/healthcare startups & entrepreneurs. Our website provides a centralized repository of essential information required for market entry.
All content on this site is based on primary resources issued by government agencies and public organizations, with direct source URLs provided for every key point. ]
​JPRO and its representative have served as advisors, supporters, and mentors for years within the primary public institutions driving Japan’s healthcare startup ecosystem: funded by Ministry of Health, Labour and Welfare (MHLW), Ministry of Economy, Trade and Industry (METI), and major local governments like Tokyo.

​
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setting up in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device, IVD >
      • IVD, LDT, RUO
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • Classification of Medical Devices
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • Comparison of Medical Device Definitions: Japan, US, & EU
      • Companion Diagnostics and Gene Panel Testing
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
      • References on Reimbursement (Cost Calculation) for Regenerative Medical Products
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
      • Overseas Expansion of Non-Medical Device Products as Medical Devices: Learning from the Case of PARO
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
      • Matching of Patents Held by Startups and Individuals
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Networking, Partnering
      • Introducing Seeds to Pharmaceutical Companies
      • Incentives (Returns) to Licensor Universities
    • References in English
  • コンテンツ一覧
    • 起業、法人設立・運営 >
      • 事業計画の策定
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 実証実験支援プログラム一覧
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • PMDA RS相談活用のススメ
      • 薬事スタッフ・コンサル選定ガイド
      • 都道府県薬務課一覧
      • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
    • 医薬品、再生医療等製品 >
      • 医薬品の該当性確認方法
      • 医薬品一般的名称設定のガイドライン
      • 医薬品、医療機器等の開発に当たって、参照したい資料
      • 先進医療制度
      • 一般用医薬品(OTC)
      • コンパニオン診断薬と遺伝子パネル検査
      • 再生医療等製品の保険償還(原価計算)に関する参考情報
    • 医療機器、体外診断用医薬品 >
      • 体外診、ラボ開発検査、研究用試薬
      • 医療機器該当性確認ガイド
      • 医療機器と非医療機器の機能が複合した製品は?
      • 医療機器の一般的名称と確認方法
      • 医療機器のクラス分類
      • 医療機器・体外診の保険収載概要
      • 医療機器・体外診の保険収載実務
      • SaMDの保険収載
      • 医療機器・体外診の保険収載ガイド
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
      • 医療機器とするか、非医療機器とするか
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • アカデミア研究者がPIとして応募可能なグラントリスト
      • 海外在住の日本人研究者が日本の助成金を獲得する方法
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
      • スタートアップや個人が保有する特許のマッチング
      • ライセンスを受けた大学へのインセンティブ(還元)について
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時に留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
      • ネットワーキング、パートナリング
    • 海外展開 >
      • 米国展開(主に医療機器)に、読むと役立つ情報リスト
      • 米国FDAにおける、医療機器該当性の確認ステップ
      • 米国における、医療機器の申請データ・試験計画の相談方法((Pre-Submission/Q-Submission
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
      • 非医療機器製品の海外での医療機器展開
      • 欧州医療機器規則MDRに関する資料
      • 欧州MDRにおける、医療機器該当性の確認方法
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報